Navigation and service

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy

OK

JoHM S6/2020 – Corrigendum

Migraine and tension-type headache in Germany. Prevalence and disease severity from the BURDEN 2020 Burden of Disease Study

Porst M, Wengler A, Leddin J, Neuhauser H, Katsarava Z et al. (2020)
Journal of Health Monitoring 5(S6): 2–24. DOI 10.25646/6990.2

In the original version, the drug ‘metamizole sodium’ was shown twice in table 4, both as the active ingredient itself as well as a preparation containing the active ingredient (trade name ‘Novaminesulfone’). In the corrected version, table 4 shows the order of medications after merging the two entries (i.e. assigning the brand ‘Novaminesulfone’ to the group of ‘metamizole sodium’).

In the running text on page 14, the sentence “Therefore, triptans are particularly taken by people with migraine and are ranked at place four with 7.3%.” has been corrected accordingly. The correct sentence reads: “Therefore, triptans are particularly taken by people with migraine and are ranked at place five with 7.3%.”

Date of issue November 30, 2020 PDF (59 KB, File does meet accessibility standards.)